BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 8539083)

  • 1. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
    de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
    Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
    Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Mahmoud MS
    J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
    Werner H; Matuschka FR; Brandenburg I
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
    Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
    Aguirre-Cruz L; Sotelo J
    J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
    Moshkani SK; Dalimi A
    Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
    Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
    J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.